TheEdgeResearch
Home / Stocks / ICLR

ICON Public Limited Company (ICLR)

NASDAQ Healthcare Medical - Diagnostics & Research
$166.48 ▲ +0.55%
Market Cap
$12.75B
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
1.20
52-Wk Range
66.57-203.91
CEO
Barry Balfe
Country
IE
Currency
USD

ICON Public Limited Company operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Dublin, DU, IE. The stock last traded at $166.48, up 0.55% on the session, giving a market capitalisation of $12.75B. On trailing twelve-month figures it carries a trailing P/E of 38.80, a net margin of 4.0%. Its beta of 1.20 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
38.80
Price / Sales
1.54
Price / Book
1.36
EV / EBITDA
12.30
Gross margin
21.8%
Operating margin
10.1%
Net margin
4.0%
Return on equity
Debt / equity
0.37
Current ratio
0.95
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ
Employees
40,200
IPO date
1998-05-15
Headquarters
Dublin, DU, IE
About ICON Public Limited Company

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.

Comparable companies

ICON Public Limited Company is most often compared with the following Healthcare names:

COOEHCEXASGHMEDPNBIXQGENRVTYSOLVUHS
More research on ICLR
ICLR technical analysis ICLR TheEdge Score Compare against peers
Open full interactive analysis & DCF →